ferumoxytol
Selected indexed studies
- Ferumoxytol: an emerging therapeutic for iron deficiency anemia. (Expert Opin Pharmacother, 2023) [PMID:36471920]
- Ferumoxytol-enhanced MRI in the peripheral vasculature. (Clin Radiol, 2019) [PMID:29731126]
- Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle. (Theranostics, 2022) [PMID:34976214]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ferumoxytol: an emerging therapeutic for iron deficiency anemia. (2023) pubmed
- Ferumoxytol-enhanced MRI in the peripheral vasculature. (2019) pubmed
- Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle. (2022) pubmed
- Ferumoxytol promotes haematopoietic stem cell post-injury regeneration as a reactive oxygen species scavenger. (2025) pubmed
- Ferumoxytol for the treatment of iron deficiency anemia. (2018) pubmed
- The Story of Ferumoxytol: Synthesis Production, Current Clinical Applications, and Therapeutic Potential. (2024) pubmed
- Ferumoxytol-enhanced cardiovascular magnetic resonance imaging: applications and technical advances. (2025) pubmed
- Cardiovascular MRI with ferumoxytol. (2016) pubmed
- Editorial Comment: Ferumoxytol-Is It Worth Adopting in Pediatric Radiology? (2023) pubmed
- The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts. (2024) pubmed